Naturally-occurring estradiol-17β-fatty acid esters, but not estradiol-17β, preferentially induce mammary tumorigenesis in female rats: Implications for an important role in human breast cancer

Toxicology and Applied Pharmacology

Volumn 229, Issue 3, 2008, Pages 332-341

  Mills, Laura H ^a   Yu, Jina ^a   Xu, Xiao Meng ^b   Lee, Anthony J ^a   Zhu, Bao Ting ^a  

^a Shimane University School of Medicine   (United States)

^b Lexington Medical Center   (United States)

Author keywords

17 estradiol; Bioactive estrogen metabolites; Breast cancer; Estrogen 17 fatty acid esters; Pituitary tumor

Indexed keywords

ESTERASE; ESTRADIOL; ESTRADIOL 17 PALMITATE; ESTRADIOL 17 STEARATE; ESTROGEN; FATTY ACID ESTER; HYPOPHYSIS HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CATALYSIS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FEMALE; HYPOPHYSIS TUMOR; MAMMARY GLAND; NONHUMAN; RAT;

ANIMALS; BREAST NEOPLASMS; CARCINOGENICITY TESTS; ESTERASES; ESTRADIOL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; PALMITATES; PITUITARY NEOPLASMS; RATS; RATS, INBRED ACI; UTERUS;

ANIMALIA; RATTUS;

EID: 44349185474     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.042     Document Type: Article

References (35)

1. Abul-Hajj Y.J. Formation of estradiol-17β fatty acyl 17-esters in mammary tumors. Steroids 40 (1982) 149-155
2. Banerjee S., Katz J., Levitz M., and Finlay T.H. Purification and properties of an esterase from human breast cyst fluid. Cancer Res. 51 (1991) 1092-1098
3. Feigelson H.S., and Henderson B.E. Estrogens and breast cancer. Carcinogenesis 17 (1996) 2279-2284
4. Grady D., and Ernster V.L. Endometrial Cancer. In: Schottenfeld D., and Fraumeni Jr. J.F. (Eds). Cancer Epidemiology and Prevention. 2nd edition (1996), Oxford University Press, New York, Oxford 1058-1089
5. Harvell D.M.E., Strecker T.E., Tochacek M., et al. Rat strain-specific actions of 17β-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveloar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2779-2784
6. Harvell D.M.E., Strecker T.E., Xie B., et al. Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 23 (2002) 161-169
7. Hochberg R.B. Biological esterification of steroids. Endocr. Rev. 19 (1998) 331-348
8. Janocko L., Larner J.M., and Hochberg R.B. The interaction of C-17 esters of estradiol with the estrogen receptor. Endocrinology 114 (1984) 1180-1186
9. Jick H., Walker A.M., Watkins R.N., et al. Replacement estrogens and breast cancer. Am. J. Epidemiol. 112 (1980) 586-594
10. Katz J., Finlay T.H., Banerjee S., and Levitz M. An estrogen-dependent esterase activity in MCF-7 cells. J. Steroid Biochem. 26 (1987) 687-692
11. Kelsey J.L., and Gammon M.D. The epidemiology of breast cancer. CA Cancer J. Clin. 41 (1991) 146-165
12. Larner J.M., Shackleton C.H.L., Roitman E., Schwartz P.E., and Hochberg R.B. Measurement of estradiol-17-fatty acid esters in human tissues. Endocrinology 75 (1992) 195-200
13. Larner J.M., Pahuja S.L., Shackleton C.H.L., McMurray W.J., Giordano G., and Hochberg R.B. The isolation and characterization of estradiol-fatty acid esters in human ovarian follicular fluid: the identification of an endogenous long-lived and potent family of estrogens. J. Biol. Chem. 268 (1993) 13893-13899
14. Mack T.M., Pike M.C., Henderson B.E., et al. Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med. 294 (1976) 1262-1267
15. Martyn P., Smith D.L., and Adams J.B. Selective turnover of the essential fatty acid ester components of estradiol-17β lipoidal derivatives formed by human mammary cancer cells in culture. J. Steroid Biochem. 28 (1987) 393-398
16. Martyn P., Smith D.L., and Adams J.B. Properties of fatty acyl-coenzyme A: estradiol-17β acyltransferase in bovine placenta microsomes. Mol. Cell. Endocrinol. 60 (1988) 7-13
17. McDonald T.W., Annegers J.F., O'Fallon W.M., Dockerty M.B., Malkasian Jr. G.D., and Karland L.T. Exogenous estrogens and endometrial carcinoma: case control and incidence study. Am. J. Obstet. Gynecol. 127 (1977) 572-580
18. Mellon-Nussbaum S.H., Ponticorvo L., and Lieberman S. Characterization of the lipoidal derivatives of prenenolone prepared by incubation of the steroid with adrenal mitochondria. J. Biol. Chem. 254 (1979) 12500-12505
19. Mills L.H., Lee A.J., Parlow A.F., and Zhu B.T. Preferential growth stimulation of mammary glands over uterine endometrium in female rats by a naturally occurring estradiol-17β-fatty acid ester. Cancer Res. 61 (2001) 5764-5770
20. Pahuja S.L., and Hochberg R.B. A comparison of the fatty acid esters of estradiol and corticosterone synthesized by tissues of the rat. J. Biol. Chem. 264 (1989) 3216-3222
21. Pahuja S.L., Kim A.H., Lee G., and Hochberg R.B. Origin of estradiol fatty acid esters in human ovarian follicular fluid. Biol. Reprod. 52 (1995) 625-630
22. Pike M.C., Spicer D.V., Dahmoush L., and Press M.F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15 (1993) 17-35
23. Roy R., and Belanger A. Formation of lipoidal steroids in follicular fluid. J. Steroid Biochem. 33 (1989) 257-262
24. Russo J., and Russo I.H. Toward a unified concept of mammary carcinogenesis. Prog. Clin. Biol. Res. 396 (1997) 1-16
25. Schatz F., and Hochberg R.B. Lipoidal derivative of estradiol: the biosynthesis of a nonpolar estrogen metabolite. Endocrinology 109 (1981) 697-703
26. Shull J.D., Spady T.J., Snyder M.C., Johansson S.L., and Pennington K.L. Ovary-intact, but not ovariectomized female ACI rats treated with 17β-estradiol rapidly develop mammary carcinoma. Carcinogenesis 18 (1997) 1595-1601
27. Siiteri P.K., Williams J.E., and Takaki N.K. Steroid abnormalities in endometrial and breast carcinoma: a unifying hypothesis. J. Steroid Biochem. 7 (1976) 897-903
28. Spady T.J., McComb R.D., and Shull J.D. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 11 (1999) 217-233
29. Vihma V., Adlercreutz H., Titinen A., Kiuru P., Wahala K., and Tikkanen M.J. Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid. Clin. Chem. 47 (2001) 1256-1262
30. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 36 (1996) 203-232
31. Xu S., Zhu B.T., Cai M.X., and Conney A.H. Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats. J. Pharmacol. Exp. Ther. 297 (2001) 50-56
32. Xu S., Zhu B.T., and Conney A.H. Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes. J. Pharmacol. Exp. Ther. 296 (2001) 188-197
33. Xu S., Zhu B.T., and Conney A.H. Effect of clofibrate administration on the esterification and deesterification of steriod hormones by liver and extrahepatic tissues in rats. Biochem. Pharmacol. 63 (2002) 985-992
34. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 19 (1998) 1-27
35. Ziel H.K., and Finkle W.D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 293 (1975) 1167-1170